Health Condition 1: R21- Rash and other nonspecific skin eruption
Conditions
Interventions
Intervention1: Majoon-Musaffi-e-Azam: 7g (semisolid) to be taken orally twice a day with water after breakfast and after dinner for 4 weeks
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex 2. Patients in between age 12 to 60 Age Group 3. Frequently occurrence of Busoor, with or without association of following features. - Humra (Erythema) - Waja (Pain) - Hikka (Itching)
Exclusion criteria
Exclusion criteria: 1. Patients of Busoor associated with fever. 2. Patients with other inflammatory and suppurated conditions of skin e.g. Abscess, Carbuncle, and Cellulitis. 3. Patients with features of Cellulitis 4. Patients with diabetes mellitus 5. Patients with disease required long term treatment e.g. Metabolic Disorders, specific infectious disease and cancer etc. 6. Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The lesion will be evaluated according to its number, size, and associated symptoms. Grading on the basis of the number of lesions will be recorded.Timepoint: At baseline, day 7, 14, 21 and at the end of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline and after 4 weeks | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed